Amphotericin B Resistant Apophysomyces elegans Causing Rhino-oculo-Cerebral Mucormycosis in an Immunocompetent Host

August 2015
Journal of Clinical & Diagnostic Research;Aug2015, Vol. 9 Issue 8, p1
Academic Journal
Case Study
Mucormycosis, an angioinvasive infection is caused by the ubiquitous filamentous fungi of the order Mucorales and class Mucormycetes. Reports of this disease are on the rise over the past few decades. Rhino-oculo-Cerebral presentation associated with uncontrolled diabetes is the predominant characteristic of this entity. We report here a case of rhinooculocerebral mucormycosis (ROCM) due to Apophysomyces elegans (A. elegans) in a 45-year-old diabetic lady with background illness of hypothyroidism and polyradiculoneuropathy. Though this condition is usually managed with surgical debridement of the affected tissue and medical therapy with Amphotericin B, the isolate recovered in our case was found to be resistant to Amphotericin B.


Related Articles

  • Rhinocerebral Phycomycosis in Association with Diabetic Ketoacidosis. Abramson, Eugene; Wilson, Dana; Arky, Ronald A. // Annals of Internal Medicine;Apr67, Vol. 66 Issue 4, p735 

    Presents two cases of rhinocerebral phycomycosis arising in association with diabetic ketoacidosis and a review of clinical and experimental experience with amphotericin B therapy. Facts of the case; Information on the amphotericin B therapy; Clinical pattern of reported cases of rhinocerebral...

  • Alternate-day amphotericin B therapy in the treatment of rhinocerebral phycomycosis (mucormycosis). Battock, Dennis J.; Graesz, Henry; Bobrowsky, Martin; Littman, Maxwell L.; Battock, D J; Grausz, H; Bobrowsky, M; Littman, M L // Annals of Internal Medicine;Jan68, Vol. 68 Issue 1, p122 

    Reports on alternate-day amphotericin B therapy in the treatment of rhinocerebral phycomycoasis or mucormycosis. Limitation of successful treatment of rhinocerebral phycomycoasis; Factors that contribute to unsuccessful treatment; Mean 48-hour serum levels of amphoterecin B.

  • Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report. Çagatay, Atahan A.; Öncü, Serkan S.; Çalangu, Semra S.; Yildirmak, Taner T.; Özsüt, Halit H.; Eraksoy, Haluk H. // BMC Infectious Diseases;2001, Vol. 1 Issue 1, p22 

    Background: Mucormycosis (or zygomycosis) is the term for infection caused by fungi of the order Mucorales. Mucoraceae may produce severe disease in susceptible individuals, notably patients with diabetes and leukemia. Rhinocerebral mucormycosis most commonly manifests itself in the setting of...

  • Combined Antifungal Treatment of Visceral Mucormycosis with Caspofungin and Liposomal Amphotericin B. Voitl, P.; Scheibenpflug, C.; Weber, T.; Janata, O.; Rokitansky, A. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2002, Vol. 21 Issue 8, p632 

    The article presents information on combined anti-fungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B. Mucormycosis is a rare invasive opportunistic fungal infection occurring mainly in patients with diabetic ketoacidosis, malignancy or immunodeficiency. The...

  • Posakonazol ile Tedavi Edilen Rinoserebral Mukormikoz Olgusu. Demiroğlu, Yusuf Ziya; Turunç, Tuba; Erkan, Alper Nabi; Alkan, Özlem; Alışkan, Hikmet Eda; Çolakoğlu, Şule; Arslan, Hande // Klimik Journal / Klimik Dergisi;Dec2010, Vol. 23 Issue 3, p130 

    Mucormycosis is an angioinvasive disease with an acute onset, fatal and aggressive course, which is commonly seen in immunosuppressed patients. In this case report, a 55-year-old diabetic man with rhinocerebral mucormycosis who was admitted with fever, headache and periorbital cellulitis, was...

  • Amphotericin-B.  // Reactions Weekly;12/12/2015, Vol. 1581 Issue 1, p27 

    A case study by H. C. Ho and colleagues published in the journal "Clinical Ophthalmology" concerning a 63-year-old woman developed nephropathy during treatment with amphotericin b for rhino orbital cerebral mucormycosis (ROCM) and endogenous fungal endophthalmitis is presented.

  • Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study. Santos, Carolina Rocio; Tuon, Felipe Francisco; Cieslinski, Juliette; de Souza, Regina Maia; Imamura, Rui; Amato, Valdir Sabbaga // PLoS ONE;6/26/2019, Vol. 14 Issue 6, p1 

    Background: Liposomal amphotericin B (L-AMB) has been used for mucosal leishmaniasis (ML), but comparative studies on L-AMB and other drugs used for the treatment of ML have not been conducted. The present study aimed to evaluate the outcome of patients with ML who were treated with L-AMB....

  • Dexamethasone: Invasive rhinosinusal mucormycosis following medication error: case report.  // Reactions Weekly;7/13/2019, Vol. 1761 Issue 1, p134 

    No abstract available.

  • Persistent cavitations in pulmonary mucormycosis after apparently successful amphotericin B Donado-Uña, José R.; Dıaz-Hellın, Vicente; López-Encuentra, Angel; Echave-Sustaeta, José M. // European Journal of Cardio-Thoracic Surgery;May2002, Vol. 21 Issue 5, p940 

    A 67-year-old diabetic male developed bilateral pulmonary mucormycosis (PM). After long-term treatment with amphotericin B (cumulative dose of 30.6 g), clinical resolution was obtained, but small radiographic cavitations persisted. A late relapse occurred and bilateral lobectomy led to a...

  • Amphotericin B liposomal.  // Reactions Weekly;2/13/2016, Vol. 1588 Issue 1, p29 

    The article is a case report of a 19-year-old male with renal dysfunction developed while being treated with amphotericin B liposomal for cerebral mucormycosis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics